Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,305 | -119,947 | -86,113 | -56,245 | -28,147 |
| Depreciation Amortization | 138 | 546 | 414 | 283 | 143 |
| Other Working Capital | -1,226 | -1,628 | -4,205 | -4,404 | -3,010 |
| Other Operating Activity | 7,822 | 25,887 | 18,386 | 11,228 | 5,556 |
| Operating Cash Flow | $-32,571 | $-95,142 | $-71,518 | $-49,138 | $-25,458 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -120,156 | 72,604 | 38,170 | 52,937 | 32,040 |
| PPE Investments | -88 | -141 | -84 | -45 | -14 |
| Investing Cash Flow | $-120,244 | $72,463 | $38,086 | $52,892 | $32,026 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 160,383 | 8,100 | 3,417 | 2,770 | 2,187 |
| Financing Cash Flow | $160,383 | $8,100 | $3,417 | $2,770 | $2,187 |
| Beginning Cash Position | 78,387 | 92,966 | 92,966 | 92,966 | 92,966 |
| End Cash Position | 85,955 | 78,387 | 62,951 | 99,490 | 101,721 |
| Net Cash Flow | $7,568 | $-14,579 | $-30,015 | $6,524 | $8,755 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,571 | -95,142 | -71,518 | -49,138 | -25,458 |
| Capital Expenditure | -88 | -141 | -84 | -45 | -14 |
| Free Cash Flow | -32,659 | -95,283 | -71,602 | -49,183 | -25,472 |